HENRY SCHEIN, INC. Finance Lease, Right-of-Use Asset, Amortization
HENRY SCHEIN, INC. (HSIC) reported Finance Lease, Right-of-Use Asset, Amortization of $3.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-21.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2023-02-21
- HENRY SCHEIN, INC. finance lease, right-of-use asset, amortization for the quarter ending 2021-12-25 was $1.31M, a 53.40% increase year-over-year.
- HENRY SCHEIN, INC. finance lease, right-of-use asset, amortization for the quarter ending 2021-09-25 was $573.00K, a 32.03% increase year-over-year.
- HENRY SCHEIN, INC. finance lease, right-of-use asset, amortization for the quarter ending 2021-06-26 was $516.00K, a 82.98% increase year-over-year.
- HENRY SCHEIN, INC. finance lease, right-of-use asset, amortization for the quarter ending 2021-03-27 was $604.00K, a 39.81% increase year-over-year.
- HENRY SCHEIN, INC. finance lease, right-of-use asset, amortization for fiscal 2022 was $3.00M, a 0.00% change from fiscal 2021.
- HENRY SCHEIN, INC. finance lease, right-of-use asset, amortization for fiscal 2021 was $3.00M, a 50.00% increase from fiscal 2020.
- HENRY SCHEIN, INC. finance lease, right-of-use asset, amortization for fiscal 2020 was $2.00M, a 73.31% increase from fiscal 2019.
- HENRY SCHEIN, INC. finance lease, right-of-use asset, amortization for fiscal 2019 was $1.15M.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 3 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 6 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 9 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 12 month | Finance Lease, Right-of-Use Asset, Amortization 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-12-31 | $3.00M 10-K · filed 2023-02-21 | |||||||
| 2021-12-25 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $1.88M derived: sum of 2 quarters · filed 2023-02-21 | $2.40M derived: sum of 3 quarters · filed 2023-02-21 | $3.00M 10-K · filed 2023-02-21 | $2.88M 10-K · filed 2022-02-15 | |||
| 2021-09-25 | $573.00K 10-Q · filed 2021-11-02 | $1.09M derived: sum of 2 quarters · filed 2021-11-02 | $1.69M 10-Q · filed 2021-11-02 | $2.54M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-06-26 | $516.00K 10-Q · filed 2021-08-03 | $1.12M 10-Q · filed 2021-08-03 | $1.97M derived: sum of 3 quarters · filed 2023-02-21 | $2.41M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-03-27 | $604.00K 10-Q · filed 2021-05-04 | $1.46M derived: sum of 2 quarters · filed 2023-02-21 | $1.89M derived: sum of 3 quarters · filed 2023-02-21 | $2.17M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2020-12-26 | $852.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $1.29M derived: sum of 2 quarters · filed 2023-02-21 | $1.57M derived: sum of 3 quarters · filed 2023-02-21 | $2.00M 10-K · filed 2023-02-21 | $2.21M 10-K · filed 2021-02-17 | |||
| 2020-09-26 | $434.00K 10-Q · filed 2021-11-02 | $716.00K derived: sum of 2 quarters · filed 2021-11-02 | $1.15M 10-Q · filed 2021-11-02 | $1.50M derived: sum of 4 quarters · filed 2022-02-15 | ||||
| 2020-06-27 | $282.00K 10-Q · filed 2021-08-03 | $714.00K 10-Q · filed 2021-08-03 | $1.07M derived: sum of 3 quarters · filed 2022-02-15 | $1.36M derived: sum of 4 quarters · filed 2022-02-15 | ||||
| 2020-03-28 | $432.00K 10-Q · filed 2021-05-04 | $788.00K derived: sum of 2 quarters · filed 2022-02-15 | $1.08M derived: sum of 3 quarters · filed 2022-02-15 | $1.34M derived: sum of 4 quarters · filed 2022-02-15 | ||||
| 2019-12-28 | $356.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $646.00K derived: sum of 2 quarters · filed 2022-02-15 | $906.00K derived: sum of 3 quarters · filed 2022-02-15 | $1.15M 10-K · filed 2022-02-15 | ||||
| 2019-09-28 | $290.00K 10-Q · filed 2020-11-02 | $290.00M 10-Q · filed 2019-11-05 | $550.00K derived: sum of 2 quarters · filed 2020-11-02 | $798.00K 10-Q · filed 2020-11-02 | $798.00M 10-Q · filed 2019-11-05 | |||
| 2019-06-29 | $260.00K 10-Q · filed 2020-08-04 | $260.00M 10-Q · filed 2019-08-06 | $508.00K 10-Q · filed 2020-08-04 | $508.00M 10-Q · filed 2019-08-06 | ||||
| 2019-03-30 | $248.00K 10-Q · filed 2020-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/ (ACH) | United States | $0.057B | -0.87 |